The burden of HIV/AIDS in the public healthcare system

被引:8
作者
Cleary, Susan [1 ]
Boulle, Andrew
Castillo-Riquelme, Marianela
McIntyre, Di
机构
[1] Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, ZA-7700 Rondebosch, South Africa
关键词
HIV/AIDS; healthcare burden; public health;
D O I
10.1111/j.1813-6982.2008.00165.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Given current lack of routine data, assessing the burden of HIV/AIDS on the public healthcare system is complex. This research aimed to collect a wide range of data that could be used to estimate this burden and the costs of meeting it. Data collection was undertaken by research doctors who were employed in a wide spectrum of facilities to compile information on patients' HIV-status, retrospective utilisation of services and unit costs of care. Key results indicated that the percentage of expenditure on HIV-related care was 26% across all facilities. HIV-positive patients had higher utilisation of services compared to other patient groups; the annual cost per patient was estimated to be R4,813 (2007/08 prices). Results should be interpreted in the light of the underlying population need and context-specific access barriers.
引用
收藏
页码:S3 / S14
页数:12
相关论文
共 17 条
[1]   Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study [J].
Badri, M ;
Wilson, D ;
Wood, R .
LANCET, 2002, 359 (9323) :2059-2064
[2]  
Barnum H, 1993, PUBLIC HOSP DEV COUN
[3]   Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. [J].
Bozzette, SA ;
Joyce, G ;
McCaffrey, DF ;
Leibowitz, AA ;
Morton, SC ;
Berry, SH ;
Rastegar, A ;
Timberlake, D ;
Shapiro, MF ;
Goldman, DP .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :817-823
[4]  
Cleary S, 2007, EQUITY EFFICIENCY HL
[5]   The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa - A primary data analysis [J].
Cleary S.M. ;
McIntyre D. ;
Boulle A.M. .
Cost Effectiveness and Resource Allocation, 4 (1)
[6]  
HAILE B, 2000, THESIS U CAPE TOWN C
[7]   Scaling up access to antiretroviral treatment in southern Africa: who will do the job? [J].
Kober, K ;
Van Damme, W .
LANCET, 2004, 364 (9428) :103-107
[8]  
LUCE B, 1996, COST EFFECTIVENESS H, P200
[9]  
*NAT DEP HLTH, 2005, UN FEE SCHED PAT ATT
[10]   THE CONCEPT OF ACCESS - DEFINITION AND RELATIONSHIP TO CONSUMER SATISFACTION [J].
PENCHANSKY, R ;
THOMAS, JW .
MEDICAL CARE, 1981, 19 (02) :127-140